Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Cancer|January 24, 2009
Adjuvant targeted therapy in early breast cancerJohn Mackey, Deanna McLeod, Joseph Ragaz, et al.
The Lancet. Oncology|November 1, 2005
Selection of adjuvant chemotherapy for treatment of node-positive breast cancerMaureen Trudeau, Flay Charbonneau, Karen Gelmon, et al.
Cell Death & Disease|June 13, 2020
BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancerVrajesh Pandya, John Maringa Githaka, Namrata Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphismsJennifer Listgarten, Sambasivarao Damaraju, Brett Poulin, et al.
The American Journal of Pathology|October 8, 2013
Frequent infection of neurons by SV40 virus in SIV-infected macaque monkeys with progressive multifocal leukoencephalopathy and meningoencephalitisSaravanan Kaliyaperumal, Xin Dang, Christian Wuethrich, et al.
Plos Pathogens|May 14, 2009
Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2Bin Jia, Ruth Serra-Moreno, William Neidermyer, et al.
Clinical Breast Cancer|November 12, 2002
Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trialJean-Marc Nabholtz, Jacques Cantin, Jose Chang, et al.
Analytical Biochemistry|August 25, 2009
Evidence for copurification of micronuclei in sucrose density gradient-enriched plasma membranes from cell linesSambasivarao Damaraju, Nancy Zhang, Nan Li, et al.
Plos One|June 21, 2014
Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancerHemalatha Kuppusamy, Helga M Ogmundsdottir, Eva Baigorri, et al.
Cancer|October 10, 2003
Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trialLee S Rosen, David Gordon, Mary Kaminski, et al.
Pageof 5